NO313486B1 - Hurtignedbrytbar medikamentform av tramadol eller et tramadolsalt - Google Patents
Hurtignedbrytbar medikamentform av tramadol eller et tramadolsalt Download PDFInfo
- Publication number
- NO313486B1 NO313486B1 NO19963430A NO963430A NO313486B1 NO 313486 B1 NO313486 B1 NO 313486B1 NO 19963430 A NO19963430 A NO 19963430A NO 963430 A NO963430 A NO 963430A NO 313486 B1 NO313486 B1 NO 313486B1
- Authority
- NO
- Norway
- Prior art keywords
- tramadol
- tablets
- salt
- starch
- water
- Prior art date
Links
- TVYLLZQTGLZFBW-ZBFHGGJFSA-N (R,R)-tramadol Chemical compound COC1=CC=CC([C@]2(O)[C@H](CCCC2)CN(C)C)=C1 TVYLLZQTGLZFBW-ZBFHGGJFSA-N 0.000 title claims description 28
- 229960004380 tramadol Drugs 0.000 title claims description 13
- TVYLLZQTGLZFBW-GOEBONIOSA-N tramadol Natural products COC1=CC=CC([C@@]2(O)[C@@H](CCCC2)CN(C)C)=C1 TVYLLZQTGLZFBW-GOEBONIOSA-N 0.000 title claims description 13
- 229940079593 drug Drugs 0.000 title description 6
- 239000003814 drug Substances 0.000 title description 6
- 229920002472 Starch Polymers 0.000 claims description 19
- 235000019698 starch Nutrition 0.000 claims description 19
- 239000008107 starch Substances 0.000 claims description 18
- 229920000168 Microcrystalline cellulose Polymers 0.000 claims description 11
- 229940016286 microcrystalline cellulose Drugs 0.000 claims description 11
- 235000019813 microcrystalline cellulose Nutrition 0.000 claims description 11
- 239000008108 microcrystalline cellulose Substances 0.000 claims description 11
- 239000002360 explosive Substances 0.000 claims description 8
- 239000003826 tablet Substances 0.000 description 59
- 230000015556 catabolic process Effects 0.000 description 22
- 235000019589 hardness Nutrition 0.000 description 17
- 239000004480 active ingredient Substances 0.000 description 14
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 14
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 10
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 10
- 238000006731 degradation reaction Methods 0.000 description 8
- PPKXEPBICJTCRU-XMZRARIVSA-N (R,R)-tramadol hydrochloride Chemical compound Cl.COC1=CC=CC([C@]2(O)[C@H](CCCC2)CN(C)C)=C1 PPKXEPBICJTCRU-XMZRARIVSA-N 0.000 description 7
- 229960003107 tramadol hydrochloride Drugs 0.000 description 7
- WINXNKPZLFISPD-UHFFFAOYSA-M Saccharin sodium Chemical compound [Na+].C1=CC=C2C(=O)[N-]S(=O)(=O)C2=C1 WINXNKPZLFISPD-UHFFFAOYSA-M 0.000 description 6
- 239000000126 substance Substances 0.000 description 6
- 244000246386 Mentha pulegium Species 0.000 description 5
- 235000016257 Mentha pulegium Nutrition 0.000 description 5
- 235000004357 Mentha x piperita Nutrition 0.000 description 5
- 235000007265 Myrrhis odorata Nutrition 0.000 description 5
- 240000004760 Pimpinella anisum Species 0.000 description 5
- 235000012550 Pimpinella anisum Nutrition 0.000 description 5
- 239000011230 binding agent Substances 0.000 description 5
- 235000001050 hortel pimenta Nutrition 0.000 description 5
- 235000019359 magnesium stearate Nutrition 0.000 description 5
- 239000000203 mixture Substances 0.000 description 5
- 238000003825 pressing Methods 0.000 description 5
- 239000000377 silicon dioxide Substances 0.000 description 5
- 235000012239 silicon dioxide Nutrition 0.000 description 5
- 229920002261 Corn starch Polymers 0.000 description 4
- 239000008120 corn starch Substances 0.000 description 4
- 229940099112 cornstarch Drugs 0.000 description 4
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 3
- 229930195725 Mannitol Natural products 0.000 description 3
- 239000000594 mannitol Substances 0.000 description 3
- 235000010355 mannitol Nutrition 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 239000002609 medium Substances 0.000 description 3
- 239000002245 particle Substances 0.000 description 3
- 239000000546 pharmaceutical excipient Substances 0.000 description 3
- 229920002785 Croscarmellose sodium Polymers 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 2
- 238000005422 blasting Methods 0.000 description 2
- FUFJGUQYACFECW-UHFFFAOYSA-L calcium hydrogenphosphate Chemical compound [Ca+2].OP([O-])([O-])=O FUFJGUQYACFECW-UHFFFAOYSA-L 0.000 description 2
- 239000001768 carboxy methyl cellulose Substances 0.000 description 2
- 235000019700 dicalcium phosphate Nutrition 0.000 description 2
- 230000001079 digestive effect Effects 0.000 description 2
- 239000007884 disintegrant Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 239000000945 filler Substances 0.000 description 2
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 239000008101 lactose Substances 0.000 description 2
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 2
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 2
- 230000008092 positive effect Effects 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 1
- 108010011485 Aspartame Proteins 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- UDIPTWFVPPPURJ-UHFFFAOYSA-M Cyclamate Chemical compound [Na+].[O-]S(=O)(=O)NC1CCCCC1 UDIPTWFVPPPURJ-UHFFFAOYSA-M 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 1
- 229920003085 Kollidon® CL Polymers 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical class [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 1
- 239000000783 alginic acid Substances 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 229960001126 alginic acid Drugs 0.000 description 1
- 150000004781 alginic acids Chemical class 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 239000012736 aqueous medium Substances 0.000 description 1
- 239000000605 aspartame Substances 0.000 description 1
- 235000010357 aspartame Nutrition 0.000 description 1
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 1
- 229960003438 aspartame Drugs 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229960005069 calcium Drugs 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- YYRMJZQKEFZXMX-UHFFFAOYSA-L calcium bis(dihydrogenphosphate) Chemical compound [Ca+2].OP(O)([O-])=O.OP(O)([O-])=O YYRMJZQKEFZXMX-UHFFFAOYSA-L 0.000 description 1
- 229940062672 calcium dihydrogen phosphate Drugs 0.000 description 1
- 229910000389 calcium phosphate Inorganic materials 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 235000010980 cellulose Nutrition 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 239000000625 cyclamic acid and its Na and Ca salt Substances 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 239000013583 drug formulation Substances 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 239000007938 effervescent tablet Substances 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 210000004051 gastric juice Anatomy 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 239000003979 granulating agent Substances 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 229940031703 low substituted hydroxypropyl cellulose Drugs 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 235000019691 monocalcium phosphate Nutrition 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 1
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 1
- 229960001462 sodium cyclamate Drugs 0.000 description 1
- 230000003595 spectral effect Effects 0.000 description 1
- 235000013599 spices Nutrition 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Pain & Pain Management (AREA)
- Zoology (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Rheumatology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Cosmetics (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19530575A DE19530575A1 (de) | 1995-08-19 | 1995-08-19 | Schnell zerfallende Arzneiform von Tramadol oder einem Tramadolsalz |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO963430D0 NO963430D0 (no) | 1996-08-16 |
| NO963430L NO963430L (no) | 1997-02-20 |
| NO313486B1 true NO313486B1 (no) | 2002-10-14 |
Family
ID=7769912
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO19963430A NO313486B1 (no) | 1995-08-19 | 1996-08-16 | Hurtignedbrytbar medikamentform av tramadol eller et tramadolsalt |
Country Status (29)
| Country | Link |
|---|---|
| US (1) | US5776492A (cs) |
| EP (1) | EP0759296B1 (cs) |
| JP (1) | JP4074675B2 (cs) |
| CN (1) | CN1102385C (cs) |
| AR (1) | AR003476A1 (cs) |
| AT (1) | ATE205708T1 (cs) |
| AU (1) | AU703310B2 (cs) |
| BR (1) | BR9604034A (cs) |
| CA (1) | CA2182939C (cs) |
| CZ (1) | CZ289167B6 (cs) |
| DE (2) | DE19530575A1 (cs) |
| DK (1) | DK0759296T3 (cs) |
| ES (1) | ES2164198T3 (cs) |
| GR (1) | GR3036720T3 (cs) |
| HK (1) | HK1010100A1 (cs) |
| HU (1) | HU227360B1 (cs) |
| IL (1) | IL119080A (cs) |
| MY (1) | MY113908A (cs) |
| NO (1) | NO313486B1 (cs) |
| NZ (1) | NZ299141A (cs) |
| PE (1) | PE8298A1 (cs) |
| PL (1) | PL184785B1 (cs) |
| PT (1) | PT759296E (cs) |
| RU (1) | RU2174837C2 (cs) |
| SI (1) | SI0759296T1 (cs) |
| SK (1) | SK281779B6 (cs) |
| UA (1) | UA41392C2 (cs) |
| UY (1) | UY24308A1 (cs) |
| ZA (1) | ZA966985B (cs) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN100389752C (zh) * | 1978-04-21 | 2008-05-28 | 莱博法姆公司 | 控释组合物 |
| US5989589A (en) * | 1997-10-24 | 1999-11-23 | Cartilier; Louis | Cross-linked cellulose as a tablet excipient |
| PT1058538E (pt) * | 1998-03-06 | 2002-11-29 | Eurand Int | Comprimidos de desintegracao rapida |
| SE9802973D0 (sv) * | 1998-09-03 | 1998-09-03 | Astra Ab | Immediate release tablet |
| GB9904911D0 (en) * | 1999-03-03 | 1999-04-28 | Scherer Ltd R P | Pharmaceutical compositions |
| CN1202815C (zh) * | 1999-08-31 | 2005-05-25 | 格吕伦塔尔有限公司 | 含有曲马朵糖精盐的持续释放给药剂型 |
| DE19940740A1 (de) * | 1999-08-31 | 2001-03-01 | Gruenenthal Gmbh | Pharmazeutische Salze |
| DE19940944B4 (de) * | 1999-08-31 | 2006-10-12 | Grünenthal GmbH | Retardierte, orale, pharmazeutische Darreichungsformen |
| CN1942175B (zh) * | 2002-10-25 | 2010-05-26 | 莱博法姆公司 | 24小时有效的曲马多缓释制剂 |
| US8487002B2 (en) | 2002-10-25 | 2013-07-16 | Paladin Labs Inc. | Controlled-release compositions |
| DE60322091D1 (de) * | 2002-10-25 | 2008-08-21 | Labopharm Inc | Zubereitungen mit kontrollierter freisetzung |
| AR045972A1 (es) * | 2002-10-25 | 2005-11-23 | Labopharm Inc | Formulaciones de tramadol de liberacion sostenida con eficacia de 24 horas |
| TWI319713B (en) | 2002-10-25 | 2010-01-21 | Sustained-release tramadol formulations with 24-hour efficacy | |
| US20040265375A1 (en) * | 2003-04-16 | 2004-12-30 | Platteeuw Johannes J. | Orally disintegrating tablets |
| TR201910177T4 (tr) | 2003-09-12 | 2019-08-21 | Amgen Inc | Bir sinakalset HCl içeren hızlı çözünme formülasyonu. |
| US20060172006A1 (en) * | 2003-10-10 | 2006-08-03 | Vincent Lenaerts | Sustained-release tramadol formulations with 24-hour clinical efficacy |
| US8022053B2 (en) * | 2004-11-02 | 2011-09-20 | Bayer Schering Pharma Aktiengesellschaft | Oral solid dosage forms containing a low dose of estradiol |
| CA2616204C (en) | 2005-09-09 | 2015-12-01 | Labopharm Inc. | Sustained drug release composition |
| US20090004248A1 (en) * | 2007-06-29 | 2009-01-01 | Frank Bunick | Dual portion dosage lozenge form |
| ITMI20130210A1 (it) | 2013-02-14 | 2014-08-15 | Menarini Lab | Composizioni farmaceutiche contenenti dexketoprofene e tramadolo |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3181998A (en) | 1960-08-12 | 1965-05-04 | Joseph L Kanig | Tablet disintegration |
| DE1617343B2 (de) | 1967-04-21 | 1976-04-22 | CH. Boehringer Sohn, 6507 Ingelheim | Traegermasse fuer arzneimitteltabletten |
| US4517179A (en) * | 1983-04-29 | 1985-05-14 | Pennwalt Corporation | Rapid dissolving, uniform drug compositions and their preparation |
| US4600579A (en) | 1983-06-07 | 1986-07-15 | Mallinckrodt, Inc. | N-acetyl-p-aminophenol compositions containing partially gelatinized starch and method for preparing same |
| EP0147780A3 (en) * | 1984-01-03 | 1987-03-11 | Merck & Co. Inc. | Drug delivery device |
| JPH0830005B2 (ja) | 1985-09-25 | 1996-03-27 | ゲルゲリイ、ゲルハルト | 崩壊性錠剤とその製造方法 |
| US5211957A (en) * | 1988-03-25 | 1993-05-18 | Ciba-Geigy Corporation | Solid rapidly disintegrating dosage form |
| CH675537A5 (cs) | 1988-03-25 | 1990-10-15 | Ciba Geigy Ag | |
| US5254355A (en) | 1992-05-29 | 1993-10-19 | Kraft General Foods, Inc. | Process for beverage tablets and products therefrom |
| DE4329794C2 (de) * | 1993-09-03 | 1997-09-18 | Gruenenthal Gmbh | Tramadolsalz enthaltende Arzneimittel mit verzögerter Wirkstofffreisetzung |
-
1995
- 1995-08-19 DE DE19530575A patent/DE19530575A1/de not_active Withdrawn
-
1996
- 1996-05-29 MY MYPI96002047A patent/MY113908A/en unknown
- 1996-07-17 SI SI9630318T patent/SI0759296T1/xx unknown
- 1996-07-17 DK DK96111483T patent/DK0759296T3/da active
- 1996-07-17 ES ES96111483T patent/ES2164198T3/es not_active Expired - Lifetime
- 1996-07-17 EP EP96111483A patent/EP0759296B1/de not_active Revoked
- 1996-07-17 AT AT96111483T patent/ATE205708T1/de not_active IP Right Cessation
- 1996-07-17 PT PT96111483T patent/PT759296E/pt unknown
- 1996-07-17 DE DE59607710T patent/DE59607710D1/de not_active Revoked
- 1996-07-30 BR BR9604034A patent/BR9604034A/pt not_active Application Discontinuation
- 1996-08-06 AU AU61941/96A patent/AU703310B2/en not_active Ceased
- 1996-08-07 CN CN96110917A patent/CN1102385C/zh not_active Expired - Fee Related
- 1996-08-08 CA CA002182939A patent/CA2182939C/en not_active Expired - Fee Related
- 1996-08-08 NZ NZ299141A patent/NZ299141A/en not_active IP Right Cessation
- 1996-08-09 CZ CZ19962359A patent/CZ289167B6/cs not_active IP Right Cessation
- 1996-08-09 SK SK1042-96A patent/SK281779B6/sk not_active IP Right Cessation
- 1996-08-09 JP JP21122196A patent/JP4074675B2/ja not_active Expired - Fee Related
- 1996-08-09 PE PE1996000597A patent/PE8298A1/es not_active Application Discontinuation
- 1996-08-12 AR ARP960103957A patent/AR003476A1/es not_active Application Discontinuation
- 1996-08-14 PL PL96315749A patent/PL184785B1/pl not_active IP Right Cessation
- 1996-08-14 UY UY24308A patent/UY24308A1/es not_active IP Right Cessation
- 1996-08-16 NO NO19963430A patent/NO313486B1/no not_active IP Right Cessation
- 1996-08-16 ZA ZA9606985A patent/ZA966985B/xx unknown
- 1996-08-16 IL IL11908096A patent/IL119080A/en not_active IP Right Cessation
- 1996-08-16 RU RU96116411/14A patent/RU2174837C2/ru not_active IP Right Cessation
- 1996-08-16 HU HU9602266A patent/HU227360B1/hu not_active IP Right Cessation
- 1996-08-19 US US08/699,623 patent/US5776492A/en not_active Expired - Lifetime
- 1996-08-19 UA UA96083292A patent/UA41392C2/uk unknown
-
1998
- 1998-09-25 HK HK98110961A patent/HK1010100A1/xx not_active IP Right Cessation
-
2001
- 2001-09-26 GR GR20010401577T patent/GR3036720T3/el not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO313486B1 (no) | Hurtignedbrytbar medikamentform av tramadol eller et tramadolsalt | |
| US6358526B1 (en) | Method of making tablets and tablet compositions produced therefrom | |
| US20060099250A1 (en) | Use of an aqueous solution of citric acid and a water-soluble sugar like lactitol as granulation liquid in the manufacture of tablets | |
| CA2446781C (fr) | Granules enrobes a base d'inhibiteur de l'enzyme de conversion de l'angiotensine | |
| NO330270B1 (no) | Umiddelbart opplosende farmasoytisk doseform og fremgangsmate for a danne granuler | |
| JP2010526811A (ja) | 堅牢な迅速崩壊錠剤の処方 | |
| WO2007086457A1 (ja) | 乾式直打速崩壊性錠剤 | |
| EA010972B1 (ru) | Композиция, содержащая смесь активных начал, и способ ее получения | |
| NO326259B1 (no) | Faste oralt-dispergerbare farmasoytiske formuleringer | |
| US20240000706A1 (en) | Compressed nicotine lozenge | |
| EP1830814B1 (en) | Taste masking system for non-plasticizing drugs | |
| US20110150993A1 (en) | Fine Particle Croscarmellose and Uses Thereof | |
| JP2001039894A (ja) | 圧縮タブレットのための結合剤および崩壊剤として使用される時の賦形剤の性質の増強剤としての直接圧縮性の澱粉 | |
| WO2004089343A1 (en) | Water soluble tablets | |
| US20150231099A1 (en) | Sodium Ibuprofen Tablets and Methods of Manufacturing Pharmaceutical Compositions Including Sodium Ibuprofen | |
| EP0975337B1 (en) | Fast release compressed tablet of flurbiprofen | |
| RU2818242C2 (ru) | Продукт в виде пакетика с жидкой композицией вкусовой добавки | |
| KR100642966B1 (ko) | 트라마돌 하이드로클로라이드를 함유하는 정제 | |
| MXPA96003140A (en) | Rapid desintegration medicine based on detramadol or a trama salt | |
| Kolli et al. | Formulation and evaluation of matrix tablet of ramipril | |
| AU2014200704B2 (en) | Sodium ibuprofen tablets and methods of manufacturing pharmaceutical compositions including sodium ibuprofen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM1K | Lapsed by not paying the annual fees |